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Abstract 
The world is under the threat of the novel coronavirus disease 2019 (COVID-19) caused by the severe acute 
respiratory syndrome coronavirus 2 (SARS-CoV-2). Despite several efforts to contain the disease spread, it 
still constitutes a public health emergency of international concern. Several published reports in the 
scientific literature called attention of the oral cavity as the potential route of infection, the implications for 
dental practice and the use of saliva in the diagnose of the COVID-19. The aim of this article is to provide 
an overview of the literature on the salivary glands and saliva in the context of SARS-CoV-2 infection. A 
brief discussion of taste disturbances and oral findings in COVID-19 patients is also presented. The 
literature shows that SARS-CoV-2 could infect the salivary glands. It is not possible, however, to make 
speculations regarding them as reservoirs for the SARS-CoV-2. In addition, patients with COVID-19 
presented several oral repercussions, including hyposalivation and taste disturbances. A few reports showed 
oral ulcers and blisters associated with SARS-CoV-2 infection. However, it remains not fully understood 
and might lead to erroneous assumptions. Overall, further studies are necessary to understand the real role 
of salivary glands and saliva in the context of SARS-CoV-2 infection. 
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Introduction 
The first description of human coronavirus was published in 1965 [1]. It has generally been thought 
that coronaviruses could cause future disease outbreaks [2]. Since 2002, beta coronaviruses have caused SARS-
CoV in 2002-2003, MERS-CoV in 2012, and the newly emerged SARS-CoV-2 in December 2019 [3]. The first 
case of a COVID-19, caused by SARS-CoV-2, was reported in Wuhan city, China [4].  Even though has been 
considerable debate on the origin of the COVID-19 causative virus, reports show that it is not a purposefully 
manipulated virus [4,5]. 
The SARS-CoV-2 is highly transmitted from man to man through close contact with infected patients, 
leading to rapid global spread by infected travelers from China [6,7]. In addition, substantial undocumented 
infections were found to facilitate the rapid dissemination of COVID-19 [6]. On January 30, 2020, the World 
Health Organization (WHO) declared that COVID-19 as a public health emergency of international concern 
[6,7]. According to the most recent data from the Johns Hopkins Coronavirus Resource Center 
(https://coronavirus.jhu.edu), the global number of confirmed cases of COVID-19 was 8.407.325 with 450.716 
deaths on June 18. 
Several published reports had drawn attention to the oral cavity as the main route of infection [8], the 
implications for dental practice [9] and the potential use of saliva in the diagnose of the COVID-19 [10,11]. A 
recent communication suggested the hyposalivation as responsible for exposing patients to a higher risk of 
getting coronavirus disease [12]. Besides, taste loss was reported in COVID‐19‐positive patients [13]. The 
aim of this article is to provide a brief overview of the literature on the salivary glands and saliva in the context 
of SARS-CoV-2 infection. A brief discussion of taste disturbances and oral findings in COVID-19 patients is 
also presented. 
 
SARS-CoV-2 Infection 
The SARS-CoV-2 uses angiotensin-converting enzyme-2 (ACE2) as an important receptor for entry 
into target cells and replication. SARS-CoV-2 employs the cellular transmembrane serine protease 2 
(TMPRSS2) for spike protein priming and the inhibition of TMPRSS2 could at least partially protect against 
SARS-CoV-2 infection [14]. In addition, the viral spike protein of SARS-CoV-2 appears to be dependent of 
sialic acid-rich proteins and monosialotetrahexosylgangliosides (gangliosides GM1) [15]. Gangliosides are 
glycosphingolipids containing sialic acid found in mammalian tissues but are most abundant in the brain [16]. 
The gangliosides GM1 are primarily recognized as essential components of membrane rafts, which play an 
important role in many cellular processes, including pathogen entry [17]. 
 
Salivary Glands and Saliva 
The three pairs of major (submandibular, parotid and sublingual) and minor salivary glands secrete 
saliva in the mouth. Saliva presents diverse functions, including lubrication, initiation of digestion, and 
immunity [18]. It is a biofluid rich in water, ions, and several protein groups, including mucins, which are 
proteins glycosylated, and most have high sialic acid content [19]. In addition, a range of disease biomarkers 
are recognized in saliva [20]. 
The expression of SARS-CoV-2 has been detected in the oral epithelium [8] and in cough out [10,21] 
and swabs of human saliva [22]. These studies point to the importance of saliva for diagnostic strategies. It is 
worth noting, however, that the source of the virus in some studies were not investigated [10,21]. In one 
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study, the tongue of each patient was lifted and saliva was collected directly from the submandibular duct, 
which drains saliva from each bilateral submandibular and sublingual glands [22]. Interestingly, the 
expression of SARS-CoV-2 was found in four out of 31 (12.90%) COVID-19 patients [23]. Another important 
finding of the study of Chen and colleagues [23] was that expression of SARS-CoV-2 was higher in critically-
ill patients (3/4), which suggested the virus invasion due to high viral loads or destroyed salivary glands at the 
late stage of the disease [23]. 
Additionally, analysis of ACE2 in human organs showed a high expression of ACE2 in minor salivary 
glands [24]. Besides the high content of sialic acids in salivary mucin, the salivary glands were shown to 
present gangliosides GM1 [25] and TMPRSS2 [26]. Overall, the literature suggests that SARS-CoV-2 could 
infect salivary glands [23]. Given the actual body of evidence, it is not possible, however, to make speculations 
regarding them as reservoirs for SARS-CoV-2. 
 
Saliva as a Diagnostic Tool 
Early disease detection is crucial to reduce disease severity and prevent complications [27]. Saliva 
shows high potential for monitoring general health and disease due to its abundance in disease biomarkers and 
the advantages of being an easy, safe, cost-effective and non-invasive diagnostic approach [27,28]. Recent 
research suggests that saliva can be used as a viable diagnostic fluid for the detection of COVID-19 [11,29,30]. 
Saliva was found to be even more sensitive for SARS-CoV-2 detection in COVID-19 patients than 
nasopharyngeal swabs [31]. This biological fluid could also enable at-home self-administered sample collection 
for accurate large-scale SARS-CoV-2 testing [29,31]. 
 
Hyposalivation 
The salivary gland secretion is dependent on several factors, including temperature, circadian rhythm 
and intensity and type of chemosensory, masticatory, or tactile stimulation [20]. Hyposalivation, the reduction 
of unstimulated salivary flow rate, is a common finding in patients mainly reported as a consequence of the use 
of medication and psychological processes [32]. 
Dry mouth was shown to be manifested in a relatively high proportion of COVID-19 patients [23]. A 
recent communication has drawn attention to hyposalivation as responsible for exposing patients to a higher 
risk of getting COVID-19 once the presence of many proteins with antiviral properties in saliva could be 
reduced [12]. Interestingly, the SARS-CoV-2 infection is more severe in individuals over 50 years of age and 
with the presence of associated comorbidities such as diabetes, cardiovascular problems and diseases involving 
the nervous system [33-35]. It is known that salivary flow reduces with age and is not explained based on 
medications used by older adults [36]. Besides, diabetes and medications for systemic disorders have also been 
associated with hyposalivation [37,38]. It is known that infectious and inflammatory processes might also lead 
to hyposalivation [39,40]. Thus, the possibility of qualitative and quantitative disturbances in saliva secretion 
by SARS-CoV-2 infection in the salivary gland should not be discarded. 
 
Taste Disorders 
Taste disorders have been reported in a variety of clinical problems [41]. Amblygeustia, a diminished 
sensitivity of taste, was shown to be manifested by a relatively high proportion of patients with COVID-19 
[23]. In a study, in which patients with influenza‐like symptoms underwent COVID-19 testing, smell and 
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taste loss were reported in 68% (40/59) and 71% (42/59), respectively, of COVID‐19‐positive patients 
suggesting that chemosensory dysfunction should be considered when screening symptoms [13]. 
Low salivary rate and disturbances in salivary biomarkers were suggested to cause xerostomia 
[42,43], which has been associated with taste sensorial complaints. Moreover, oral neuropathy or neurological 
transduction interruption induced by salivary compositional alterations is responsible for oral sensory 
complaints and loss of taste function [44,45]. Possible taste alterations as a result of the direct effect of SARS-
CoV-2 infection in sensory neurons or other components of the peripheral gustatory system should also be 
considered. 
 
Oral Findings 
It is known that the oral cavity may exhibit manifestations of underlying diseases such as oral 
ulcerations, gingival bleeding, glossitis, oral pain, or halitosis [46].  Numerous viral diseases can affect the oral 
cavity, either directly or secondarily as a result of a systemic disorder. In addition, the oral manifestations of 
viral infections may vary but are usually manifested as either ulceration or blistering in oral tissues [47-49]. 
To the best of our knowledge, the scientific literature lacks reports of oral findings associated with previous 
coronaviruses. The misdiagnose of the oral findings related to COVID-19 is possible as it shares a common 
etiological course with several other dermatological manifestations. A case report suggested that recurrent oral 
ulcers could be an inaugural symptom of COVID-19 [50]. In addition, a report of three cases (two suspicious 
and one confirmed) showed that pain and intraoral manifestations such as oral ulcers or blisters before seeking 
medical advice were a common finding in COVID-19 [51]. Thus, it was encouraged to perform intraoral 
examinations in patients suspected of SARS-CoV-2 [51]. 
As the oral findings are still new in the literature, their occurrence may vary significantly among 
COVID-19 patients and, thus, the associated systemic diseases and/or poor oral health may be a contributory 
factor to the oral presentations. Given the possibility of immunocompromised statuses of the patients, it is also 
possible that the oral manifestations may be related to other viruses (e.g., herpes simplex, varicella zoster, and 
human immunodeficiency) [47-49]. As research is still ongoing and intraoral examinations have not yet been 
considered when screening for this disease, literature still lacks evidence to understand better the underlying 
mechanisms of the oral findings in COVID-19 patients. Thus, it is not possible to affirm that the oral findings, 
reported in the literature, are direct manifestations of SARS-CoV-2 infection. 
 
Conclusion 
The SARS-CoV-2 infection is responsible for several events in the mouth, including hyposalivation 
and taste disturbances. A few reports showed oral ulcers and blisters associated with SARS-CoV-2 infection. 
However, it remains not fully understood and might lead to erroneous assumptions. Studies are necessary to 
understand the real role of salivary glands and saliva in this disease context. 
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